Targeting the HGF/Met signaling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert opinion on therapeutic …, 2012 - Taylor & Francis
Introduction: Under normal conditions, hepatocyte growth factor (HGF)-induced activation of
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …
[PDF][PDF] Targeting the HGF/Met signaling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert Opin. Ther. Targets, 2012 - researchgate.net
Area covered: The prevalence of HGF/Met pathway activation in human malignancies has
driven rapid growth in cancer drug development programs. The authors review Met structure …
driven rapid growth in cancer drug development programs. The authors review Met structure …
Targeting the HGF/Met signaling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert opinion on …, 2012 - pubmed.ncbi.nlm.nih.gov
Introduction Under normal conditions, hepatocyte growth factor (HGF)-induced activation of
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …
its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …
[引用][C] Targeting the HGF/Met signaling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert Opinion on Therapeutic Targets, 2012 - cir.nii.ac.jp
Targeting the HGF/Met signaling pathway in cancer therapy | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
[HTML][HTML] Targeting the HGF/MET signalling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert opinion on therapeutic …, 2012 - ncbi.nlm.nih.gov
Introduction—Under normal conditions, hepatocyte growth factor (HGF)-induced activation
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
Targeting the HGF/Met signaling pathway in cancer therapy.
F Cecchi, DC Rabe, DP Bottaro - Expert Opinion on Therapeutic …, 2012 - europepmc.org
Introduction—Under normal conditions, hepatocyte growth factor (HGF)-induced activation
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
[PDF][PDF] Targeting the HGF/MET signalling pathway in cancer therapy
F Cecchi, DC Rabe, DP Bottaro - Expert Opin Ther Targets, 2012 - academia.edu
Introduction—Under normal conditions, hepatocyte growth factor (HGF)-induced activation
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
of its cell surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine …
Targeting the HGF/Met signaling pathway in cancer therapy.
F Cecchi, DC Rabe, DP Bottaro - Expert Opinion on Therapeutic …, 2012 - europepmc.org
Under normal conditions, hepatocyte growth factor (HGF)-induced activation of its cell
surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …
surface receptor, the Met tyrosine kinase (TK), is tightly regulated by paracrine ligand …